BHVN
BiohavenCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
Current thesis
Composite grade C from latest DB weights. Momentum 67.7 / Value 41.0
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +36.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
68
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-08 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $21.54
Why
Momentum68 · Δ7d +36.0
Value41 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
68
52% active weight
Current posture
7d trendImproving
Δ7d
+36.0
Δ21d
+62.3
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 67.7 / Value 41.0
Fundamentals (TTM)As of 2026-06-08
Fundamentals (TTM)
As of 2026-06-08
Market Cap
$1.67B
Beta
3.56
Shares Out
132.64M
P/E (TTM) · Derived
-1.8
P/S (TTM)
-
P/FCF (TTM) · Derived
-2.00
Rev YoY
-
EPS YoY
+3.5%
Gross Margin
-
Op Margin
-
Net Debt
-$485.99M
Current Ratio
2.86
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology